GOLDMAN SACHS GROUP INC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 58 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$8,000
-82.2%
11,344
-47.8%
0.00%
Q1 2022$45,000
-45.8%
21,726
-24.2%
0.00%
Q4 2021$83,000
-69.6%
28,671
-55.5%
0.00%
Q3 2021$273,000
-5.9%
64,468
+17.5%
0.00%
Q2 2021$290,000
-44.9%
54,882
-51.5%
0.00%
Q1 2021$526,000
+205.8%
113,104
+117.4%
0.00%
Q4 2020$172,000
-10.9%
52,024
-10.7%
0.00%
Q3 2020$193,000
-4.0%
58,260
-2.6%
0.00%
Q2 2020$201,000
+131.0%
59,791
+164.6%
0.00%
Q1 2020$87,000
+14.5%
22,596
+79.6%
0.00%
Q4 2019$76,000
-28.3%
12,582
-10.6%
0.00%
Q3 2019$106,000
+86.0%
14,068
+34.0%
0.00%
Q1 2019$57,000
-5.0%
10,495
-47.9%
0.00%
Q4 2018$60,000
-71.0%
20,139
-20.7%
0.00%
Q3 2018$207,000
-52.5%
25,385
-43.3%
0.00%
Q2 2018$436,000
+209.2%
44,785
+166.2%
0.00%
Q3 2017$141,000
-92.0%
16,821
-83.8%
0.00%
Q2 2017$1,763,000
-23.4%
103,905
-9.3%
0.00%
Q1 2017$2,303,000114,6000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders